EUVIMEDEUVIMED entdecken
Open Access

Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis

Samar E Atteih iD, Catherine R Armbruster, Yasmin Hilliam, Glenn J Rapsinski, Junu Koirala Bhusal, Leah L Krainz, Jordan R Gaston, Matthew DuPont, Anna C Zemke, John F Alcorn, John A Moore, Vaughn S Cooper und 3 weitere

Pediatric Pulmonology · 2024

DOI: 10.1002/ppul.26898 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Pulmonology, 2024. Verfasst von Samar E Atteih und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Pulmonology, Department of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, …. Hauptthemen laut MEDLINE: Cystic Fibrosis, Aminophenols, Quinolones, Respiratory Mucosa. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

While the widespread initiation of elexacaftor/tezacaftor/ivacaftor (ETI) has led to dramatic clinical improvements among persons with cystic fibrosis (pwCF), little is known about how ETI affects the respiratory mucosal inflammatory and physiochemical environment, or how these changes relate to lung function.

Methods

We performed a prospective, longitudinal study of adults with CF and chronic rhinosinusitis (CF‐CRS) followed at our CF center ( n = 18). Endoscopic upper respiratory tract (paranasal sinus) aspirates from multiple visit dates, both pre‐ and post‐ETI initiation, were collected and tested for cytokines, metals, pH, and lactate levels. Generalized estimating equations were used to identify relationships between ETI and upper respiratory tract (URT) biomarker levels, and between URT biomarkers and lung function or clinical sinus parameters.

Results

ETI was associated with decreased upper respiratory mucosal cytokines B‐cell activating factor (BAFF), IL‐12p40, IL‐32, IL‐8, IL‐22 and soluble tumor necrosis factor‐1 (sTNFR1), and an increase in a proliferation‐inducing ligand (APRIL) and IL‐19. ETI was also associated with decreased URT levels of copper, manganese, and zinc. In turn, lower URT levels of BAFF, IL‐8, lactate, and potassium were each associated with ~1.5% to 4.3% improved forced expiratory volume in 1 s (FEV 1 ), while higher levels of IFNγ, iron, and selenium were associated with ~2% to 10% higher FEV 1 .

Conclusions

Our observations suggest a dampening of inflammatory signals and restriction in microbial nutrients in the upper respiratory tract with ETI. These findings improve our understanding of how ETI impacts the mucosal environment in the respiratory tract, and may give insight into the improved infectious and inflammatory status and the resulting clinical improvements seen in pwCF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisAminophenolsQuinolonesRespiratory MucosaBenzodioxolesHumansFemaleMaleProspective StudiesAdultLongitudinal StudiesYoung AdultCytokinesSinusitisRhinitisIndolesDrug CombinationsChronic DiseasePyridinesBiomarkersInflammation

Stichwörter der Autor:innen

ETIchronic rhinosinusitiscystic fibrosishighly effective modulator therapy

Substanzen

AminophenolsQuinolonesBenzodioxolesCytokinesIndolesDrug CombinationsPyridinesBiomarkersivacaftortezacaftor

Autor:innen und Institutionen

  • Division of Pediatric Pulmonology, Department of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire, USA.
  • Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Microbiology and Molecular Genetics, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Department of Pediatrics, University of Pittsburgh Medical Center, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Samar E Atteih, Erick Forno

Förderung

  • NHLBI NIH HHS
  • NIDDK NIH HHS

Zitieren

APA

Atteih, S. E., Armbruster, C. R., Hilliam, Y., Rapsinski, G. J., Bhusal, J. K., Krainz, L. L., Gaston, J. R., DuPont, M., Zemke, A. C., Alcorn, J. F., Moore, J. A., Cooper, V. S., Lee, S. E., Forno, E., & Bomberger, J. M. (2024). Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26898

Vancouver

Atteih SE, Armbruster CR, Hilliam Y, Rapsinski GJ, Bhusal JK, Krainz LL, et al. Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26898

BibTeX
@article{Atteih2024,
  author = {Atteih, Samar E and Armbruster, Catherine R and Hilliam, Yasmin and Rapsinski, Glenn J and Bhusal, Junu Koirala and Krainz, Leah L and Gaston, Jordan R and DuPont, Matthew and Zemke, Anna C and Alcorn, John F and Moore, John A and Cooper, Vaughn S and Lee, Stella E and Forno, Erick and Bomberger, Jennifer M},
  title = {Effects of highly effective modulator therapy on the dynamics of the respiratory mucosal environment and inflammatory response in cystic fibrosis},
  journal = {Pediatric Pulmonology},
  year = {2024},
  doi = {10.1002/ppul.26898}
}
Kostenlos starten →